Skip to content
OpenCapital
Get started

PAVmed Inc. PAVM Q4 2025 Annual earnings

Reported March 26, 2026 · After market close

Revenue$52.0KBeat by $27.0KDiluted EPS-$2.05Beat by $2.45
Revenue estimate$25.0K
EPS estimate-$4.50

Next report

Aug 13, 2026 (in a month)
Revenue estimate$48.0K
EPS estimate-$0.63

Versus estimates

Revenue

Q1 2026$22.0KMiss by $52.0K
Q4 2025$52.0KBeat by $27.0K
Q3 2025$5.0KMiss by $7.5KQ2 2025$6.0KMiss by $4.0KQ1 2025$8.0KMiss by $2.0KQ4 2024$10.0KMiss by $11.0K

Diluted EPS

Q1 2026-$1.17Miss by $0.48
Q4 2025-$2.05Beat by $2.45
Q3 2025-$8.41Miss by $2.40Q2 2025-$0.05Beat by $0.20Q1 2025-$0.07Beat by $0.22Q4 2024-$0.06Beat by $0.34

Ask the moment PAVmed Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did PAVmed Inc. report Q4 2025 earnings?
PAVmed Inc. (PAVM) reported Q4 2025 earnings on March 26, 2026 after market close.
What were PAVmed Inc.'s Q4 2025 revenue and EPS?
PAVmed Inc. reported revenue of $52.0K and diluted EPS of $-2.05 for Q4 2025.
Did PAVmed Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $25.0K by $27.0K. EPS beat the consensus estimate of $-4.50 by $2.45.
How did PAVmed Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 420.0% from $10.0K a year earlier and diluted EPS declined 3316.7% from $-0.06.
Where can I find PAVmed Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001493152-26-013264) and the 10-K periodic report (0001437749-26-010115) directly on SEC EDGAR. The filing index links above go to sec.gov.